Researchers have built a platform that programs short DNA fragments inside living cells to control protein activity, all without editing or altering the cell’s genome. The system, published in Nature ...

Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more Etoro is a well-known investment ...

While the market fixates on short-term product cycles, Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized ...